| Entité | Type d'entité | Industrie | |
|---|---|---|---|
IOTA Pharmaceuticals Ltd.
 IOTA Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology IOTA Pharmaceuticals Ltd. is a pharmaceutical discovery services company. Its services include virtual screening packages, surface Plasmon resonance (SPR) screening package, high-sensitivity biochemical screening package, nuclear magnetic resonance (NMR) screening package, and co-crystallography of fragment-based leads. The company was founded by Paul England and David Bailey in 2007 and is headquartered in Cambridge, the United Kingdom.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Relation dans plusieurs entreprises
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Cambridge | College/University | Doctorate Degree | |
| University of London | College/University | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder |
Internationale
| Royaume-Uni | 5 |
| Etats-Unis | 3 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Opérationnelle
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| President | 1 |
| Doctorate Degree | 1 |
| Insiders | |
|---|---|
| David Stanley Bailey | 7 |
| Susan Mary Boyd | 1 |
